Testing a new medication for newly diagnosed T-cell lymphoma

This trial is testing a new medication called golidocitinib to see if it can help people with a rare blood cancer called peripheral T-cell lymphoma. Researchers want to know whether the medication works well on its own or combined with standard chemotherapy, and whether it is safe to use. The study will follow 30 newly diagnosed patients for up to 2 years to measure how well the treatment controls their disease.

Peripheral T-cell lymphoma is a rare and aggressive cancer, and current treatments don't work well enough for all patients. Researchers believe this new medication may be more effective and help people live longer without their disease getting worse.